Find a TenderPlanned procurementPreliminary market engagement notice
Published 24 Mar 2026, 12:16 GMT

Official UK procurement notice

Supply and support of High-Throughput Blood Group Genotyping

Authority: NHS Blood and Transplant (Central government)

GoodsAbove thresholdSME suitable
Sectors: Medical Devices & Pharma (33) Delivery: Delivery location not published
Planned pipeline value£2,000,000pipeline notice, not a live tender
Tender notice expected 31 Aug 2026from the planned procurement notice
Contract term 4 yrsends 28 Feb 2031 · up to 28 Feb 2033 with extensions · starts 1 Mar 2027

What is being bought

Published requirement description

NHS Blood & Transplant (NHSBT) Genomics function intends to undertake a tender exercise for the supply and support of high-throughput blood group genotyping.

We would like to work with future suppliers of choice to procure a high-throughput Human Erythrocyte Antigen (HEA) and Human Leukocyte Antigen (HLA) genotyping system in an efficient, timely and cost-effective manner to meet the demands and expectations of our customers and the patients we serve.

Prior to commencing a formal procurement process and to help inform our strategy, NHSBT is seeking to engage with suppliers of commercially available high-throughput solutions that can be used for genotyping red cell types (HEA) and HLA types. NHSBT would like to improve our knowledge of all current and future systems available in the marketplace. This will aid identification of opportunities and gauge market interest in this field.

NHSBT requires a high-throughput (20,000 – 80,000 test per annum) blood group genotyping solution that provides either:

equipment and consumables to genotype blood group genetic variants

or

equipment and consumables to genotype blood group genetic variants and blood group typing software to generate predicted HEA and HLA types

The proposed solution must enable genotyping of blood group variants associated with an extended panel of red cell blood groups (Appendix 1).

The solution must enable the determination of Human Leukocyte Antigen (HLA) types (alleles) at the following genes: HLA-A, HLA-B, HLA-C, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-DQA1, HLA-DQB1, and HLA-DPB1.

Blood group genotyping software for both HEA and HLA typing must support compliance with relevant national and international typing and clinical standards, including ISBT, JPAC, and IPD-IMGT/HLA.

Respondents will be invited to pre-procurement engagement meetings on the 4th, 5th and/or 6th May 2026 these will be held remotely. To enable NHSBT to finalise arrangements (e.g. send meeting details and agree time slots) for the supplier engagement meetings, interested organisations are required to send an expression of interest via email to [email protected] by no later than 17:00 hrs (GMT) on 23/03/2026. This should include a list of your potential attendees and a brief overview (or a website link) of the Goods / Services which might be offered. Please include options, if available, to offer a managed service contract.

No business whatsoever is guaranteed under any resulting framework agreement or contract, and there is no guarantee that any framework agreement or contract will be put in place in relation to this notice. No compensation etc. will be paid if a tender or resulting framework agreement is withdrawn for any reason. Bidders should take part in this process only on the basis that they fully understand and accept this position.

It should be noted that this procurement exercise may allow other Health authorities to utilise any contracts/ framework agreements awarded.

Appendix 1 – HEA blood group systems

ABO

Rh

Kell

Duffy

Kidd

MNS

Dombrock

Colton

Cromer

Diego

Knops

Lutheran

LW

Scianna

Cartwright (Yt)

Vel

P1PK (P system)

Wright

CPV: Medical equipments

The lotProcurement structure

single lot · no lot value published
Lot #1PlannedRenewal 4 yrsSME
Contract period: 1 Mar 2027 – 28 Feb 2031 (4 yrs) · up to 28 Feb 2033 with extensions
Eligibility: SME eligible
Extensions: Extension options published

Who is likely to bid for this lot ↓

Pipeline intelligence · planning stage: how this market runs before the tender is published

How NHS Blood and Transplant buys Medical equipments (CPV 3310), and who usually turns up

NHS Blood and Transplant’s published record next to the market for the same work. Frameworks and DPS are left out: they draw different bid counts. Whole-market view: Medical equipments (CPV 3310) →

1

How the contest usually goes

Winner shares use published awards; bid and price charts use contested lots.

Question for the bid
This buyerNHS Blood and Transplant · division 33
What to do with it
How often do SMEs win?
i

How often small and medium firms win.

Share of awards where the winner’s size is known.

The counts under this question show how many awards have a known supplier size.

Last 36 months.

Buyer: 5 of 10 known-size awards · market: CPV 3310 · South West England (authority’s region), n=17
50%41%

Small firms have won here. Neither number says whether you qualify; it describes who has been winning.

How often do local suppliers win?
i

How often local firms win similar work.

Winners with a registered address in the delivery region, out of awards with a known address.

Local means the winner is registered in the region where that award was delivered. The market figure counts awards delivered in South West England (authority’s region).

A local branch does not count if the registered address is elsewhere.

Last 36 months.

Buyer: 2 of 5 known-location awards · market: CPV 3310 · South West England (authority’s region), n=26
40%4%

Most of this buyer’s recorded winners were registered outside the region where that award was delivered.

How long to a decision?
i

How long buyers here take to decide after bids close.

Middle value in days from the bid deadline to the award date, on competitions that published both.

Only decided tenders count, so slow ones still waiting are not in.

Last 36 months.

Buyer: 6 decided notices · market: CPV 3310 · UK-wide, n=7
17 days45 days

Half of these awards have an award date within 17 days of the bid deadline.

How often single-bid or direct?
i

How often work is awarded with no recorded rival.

Direct awards and tenders where every published lot count shows one bid.

The market share is a minimum: some awards have no bid count.

Thin markets produce this too; it is not proof of a tailored specification.

Last 36 months.

Buyer: exactly 10 of 15 procurements with awards had no recorded rival · market: CPV 3310 · South West England (authority’s region), n=37
67%76%

Direct awards or one recorded bid are common here. Check the route before spending time on a bid.

How many bids did past lots attract?

i

How many bids past lots received.

Each colour is a bid-count range. Only competed lots with a published count are included.

Past bids do not predict this tender.

Last 36 months.

This buyer10 lots with bid counts · broad CPV 33
50% had one bid
The market19 lots with bid counts · CPV 3310 · UK-wide
37% had one bid
Buyer / market · select a colour for counts
1 bid50% / 37%
Buyer: 5 of 10 lots with published bid counts. Market: 7 of 19 lots with published bid counts.
2–340% / 53%
Buyer: 4 of 10 lots with published bid counts. Market: 10 of 19 lots with published bid counts.
4–610% / 11%
Buyer: 1 of 10 lots with published bid counts. Market: 2 of 19 lots with published bid counts.
7+0% / 0%
Buyer: 0 of 10 lots with published bid counts. Market: 0 of 19 lots with published bid counts.

How did awards compare with estimates?

i

Where winning prices landed against estimates.

Each colour shows awards below, close to or above the published estimate, one lot at a time.

Past prices are a guide, not a bid price.

Last 36 months.

This buyer13 lots with estimate and award · all categories
46% below estimate
The market7 lots with estimate and award · CPV 3310 · UK-wide
71% below estimate
Buyer / market · select a colour for counts
Below estimate46% / 71%
Buyer: 6 of 13 lots with an estimate and award. Market: 5 of 7 lots with an estimate and award.
Within ±2%23% / 0%
Buyer: 3 of 13 lots with an estimate and award. Market: 0 of 7 lots with an estimate and award.
Above estimate31% / 29%
Buyer: 4 of 13 lots with an estimate and award. Market: 2 of 7 lots with an estimate and award.
2

Assess each lot
i

What past awards tell you about each lot.

See the forecast, this buyer’s earlier suppliers and firms with relevant wins.

No supplier is confirmed as a bidder.

Open a lot for its forecast, this buyer’s previous supplier and possible competitors, from published award history, not a bid list

Lot #1CPV 331048 monthsSME suitablePublished estimate£2.0m
Expected competition
i

How many bids this lot may attract.

The forecast uses similar past competitions. The bar shows either that forecast or past bid counts; the line below says which.

Each lot shows its own forecast based on its own category; forecasts for different lots of the same notice are not comparative. The bar shows 22 past lots.

A forecast, not a list of bidders.

—No model forecast yet18% chance of a single bid
Past bids on 22 similar lots
1 bid18%
4 of 22 similar past lots received 1 bid (18%).
2–373%
16 of 22 similar past lots received 2–3 (73%).
4–69%
2 of 22 similar past lots received 4–6 (9%).
7+0%
0 of 22 similar past lots received 7+ (0%).
Comparable past lots usually drew 2 bids.
Commercial price forecast
i

Where the award price may land.

The forecast uses similar awards and the buyer’s estimate. The band covers the middle half of likely prices.

No comparable awards for this lot yet.

A statistical guide from past awards, not a price to bid.

—No model forecast yet
No comparable awards on record for this lot’s category yet. The published estimate is £2.0m, and the forecast stays empty until the market has a record to read.

Who has supplied this buyer on similar work?
i

Who has done similar work for this buyer.

Past contracts are matched by buyer, title and type of work.

A past supplier may not bid again.

No earlier contract of this buyer matches this lot on the published record.

Who could compete for this lot?
i

Who could compete for this lot?

Firms with relevant past wins. On a framework, we show firms on that agreement.

None is confirmed as a bidder.

Candidate suppliers for this notice have not been worked out yet, so this is not a verdict that nobody fits.

About this data
  • Source. Official UK public procurement notices (Find a Tender), reused under the Open Government Licence v3.0. New notices arrive through the day; the figures are rebuilt nightly.
  • Two views, kept apart. The authority’s own track record and the wider market for the same kind of work sit side by side and are never mixed. Where the local picture is too thin, a figure widens to a broader market and says which one it used.
  • Forecasts are labelled. The price forecast and its range, possible competitors and the earlier-work matches are our estimates from past awards: not published facts, not win chances and not price advice. Official notices do not say who is bidding.
  • Every figure shows what it rests on. Not every notice publishes a bid count, a value or a delivery region, so each figure carries the number of records behind it, and one built on few records is marked as such. The on a figure explains it; the counting rules are in the methodology. Spotted something wrong? Tell us.

Procedure terms & legal framework

From the official record
Legal basis
UKPGA · 2023/54 Procurement Act 2023
Procurement category
Goods
Notice status
Planned procurement
Procurement threshold
Above threshold (FTS publication)
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Competitive procedure
GPA / WTO covered
Unspecified in notice
Recurring procurement
Unspecified in notice
First published
24 Mar 2026, 12:16 GMT
Last source update
24 Mar 2026, 12:16 GMT
Authority reference
C433877
FTS notice number
2026/S 000-026754
Latest notice
Preliminary market engagement notice (UK2)
Classification (CPV)
Medical equipments
Delivery area
Not published
Official registry OCID
ocds-h6vhtk-06729a Find a Tender

How it was run

Official notice
Submission deadline
—

Timeline

24 Mar 2026 → 1 Mar 2027 · 4 dates
  1. Planning notice published215 days ago
    24 Mar 2026, 12:16 GMT
  2. Market engagement169 days ago
    8 May 2026, 23:59 BST

    Respondents will be invited to pre-procurement engagement meetings on the 4th, 5th and/or 6th May 2026 these will be held remotely. To enable NHSBT to finalise arrangements (e.g. send meeting details and agree time slots) for the supplier engagement meetings, interested organisations are required to send an expression of interest via email to [email protected] by no later than 17:00 hrs (GMT) on 23/03/2026. This should include a list of your potential attendees and a brief overview (or a website link) of the Goods / Services which might be offered.

  3. Tender notice expected54 days ago
    31 Aug 2026, 23:59 BST
  4. Today
    25 Oct 2026
  5. Contract startsin 127 days
    1 Mar 2027

Notice history

1 event · 1 release on Find a Tender
  1. Preliminary market engagement notice published
    24 Mar 2026, 12:16 GMT
    UK2

Commercial outcome & contract awards

Pipeline notice
Awards (0)
No award published
Contracts (0)
No contract published
Bid statistics
No aggregate bid statistics published

Contracting authority & participating public bodies

NHS Blood and Transplant

Contracting authorityPublic authority - central government GB-PPON: PDBY-6395-VWBP 500 North Bristol Park, Bristol, South West, BS34 7QHContact name, email, phone

Official documents & specifications (1)

Official links; attachments are not copied

Notices published for this procedure